Cargando…

A clinical review of recent findings in the epidemiology of inflammatory bowel disease

Inflammatory bowel diseases (IBD), including both Crohn’s disease and ulcerative colitis, are disorders of chronic inflammation of the gastrointestinal tract marked by episodes of relapse and remission. Over the past several decades, advances have been made in understanding the epidemiology of IBD....

Descripción completa

Detalles Bibliográficos
Autores principales: Ponder, Alexis, Long, Millie D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728155/
https://www.ncbi.nlm.nih.gov/pubmed/23922506
http://dx.doi.org/10.2147/CLEP.S33961
_version_ 1782278818425208832
author Ponder, Alexis
Long, Millie D
author_facet Ponder, Alexis
Long, Millie D
author_sort Ponder, Alexis
collection PubMed
description Inflammatory bowel diseases (IBD), including both Crohn’s disease and ulcerative colitis, are disorders of chronic inflammation of the gastrointestinal tract marked by episodes of relapse and remission. Over the past several decades, advances have been made in understanding the epidemiology of IBD. The incidence and prevalence of both Crohn’s disease and ulcerative colitis have been increasing worldwide across pediatric and adult populations. As IBD is thought to be related to a combination of individual genetic susceptibility, environmental triggers, and alterations in the gut microbiome that stimulate an inflammatory response, understanding the potentially modifiable environmental risk factors associated with the development or the course of IBD could impact disease rates or management in the future. Current hypotheses as to the development of IBD are reviewed, as are a host of environmental cofactors that have been investigated as both protective and inciting factors for IBD onset. Such environmental factors include breast feeding, gastrointestinal infections, urban versus rural lifestyle, medication exposures, stress, smoking, and diet. The role of these factors in disease course is also reviewed. Looking forward, there is still much to be learned about the etiology of IBD and how specific environmental exposures intimately impact the development of disease and also the potential for relapse.
format Online
Article
Text
id pubmed-3728155
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37281552013-08-06 A clinical review of recent findings in the epidemiology of inflammatory bowel disease Ponder, Alexis Long, Millie D Clin Epidemiol Review Inflammatory bowel diseases (IBD), including both Crohn’s disease and ulcerative colitis, are disorders of chronic inflammation of the gastrointestinal tract marked by episodes of relapse and remission. Over the past several decades, advances have been made in understanding the epidemiology of IBD. The incidence and prevalence of both Crohn’s disease and ulcerative colitis have been increasing worldwide across pediatric and adult populations. As IBD is thought to be related to a combination of individual genetic susceptibility, environmental triggers, and alterations in the gut microbiome that stimulate an inflammatory response, understanding the potentially modifiable environmental risk factors associated with the development or the course of IBD could impact disease rates or management in the future. Current hypotheses as to the development of IBD are reviewed, as are a host of environmental cofactors that have been investigated as both protective and inciting factors for IBD onset. Such environmental factors include breast feeding, gastrointestinal infections, urban versus rural lifestyle, medication exposures, stress, smoking, and diet. The role of these factors in disease course is also reviewed. Looking forward, there is still much to be learned about the etiology of IBD and how specific environmental exposures intimately impact the development of disease and also the potential for relapse. Dove Medical Press 2013-07-25 /pmc/articles/PMC3728155/ /pubmed/23922506 http://dx.doi.org/10.2147/CLEP.S33961 Text en © 2013 Ponder and Long, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Ponder, Alexis
Long, Millie D
A clinical review of recent findings in the epidemiology of inflammatory bowel disease
title A clinical review of recent findings in the epidemiology of inflammatory bowel disease
title_full A clinical review of recent findings in the epidemiology of inflammatory bowel disease
title_fullStr A clinical review of recent findings in the epidemiology of inflammatory bowel disease
title_full_unstemmed A clinical review of recent findings in the epidemiology of inflammatory bowel disease
title_short A clinical review of recent findings in the epidemiology of inflammatory bowel disease
title_sort clinical review of recent findings in the epidemiology of inflammatory bowel disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728155/
https://www.ncbi.nlm.nih.gov/pubmed/23922506
http://dx.doi.org/10.2147/CLEP.S33961
work_keys_str_mv AT ponderalexis aclinicalreviewofrecentfindingsintheepidemiologyofinflammatoryboweldisease
AT longmillied aclinicalreviewofrecentfindingsintheepidemiologyofinflammatoryboweldisease
AT ponderalexis clinicalreviewofrecentfindingsintheepidemiologyofinflammatoryboweldisease
AT longmillied clinicalreviewofrecentfindingsintheepidemiologyofinflammatoryboweldisease